Corporate News     29-Nov-24
Zomato successfully concludes QIP issue
To allot 33.64 cr equity shares to eligible QIBs
Zomato has approved the allotment of 33,64,73,755 equity shares at an issue price of Rs 252.62 per equity share (including a premium of Rs 251.62 per equity share), which is at a discount of 5% to the floor price of Rs 265.91 per equity share, to the eligible qualified institutional buyers.
Previous News
  Nifty June futures trade at premium
 ( Market Commentary - Futures Market 03-Jun-25   16:12 )
  Zomato consolidated net profit rises 388.89% in the September 2024 quarter
 ( Results - Announcements 22-Oct-24   17:39 )
  Nifty May futures trade at premium
 ( Market Commentary - Futures Market 26-May-25   16:20 )
  Stock Alert: Anant Raj, Zomato, Paytm, Allcargo Terminals, LIC
 ( Market Commentary - Stock Alert 18-Feb-25   08:31 )
  Zomato consolidated net profit rises 12550.00% in the June 2024 quarter
 ( Results - Announcements 01-Aug-24   15:50 )
  Nifty January futures trade at premium
 ( Market Commentary - Futures Market 30-Dec-24   16:26 )
  Zomato Q2 PAT soars to Rs 176 cr
 ( Hot Pursuit - 22-Oct-24   17:55 )
  Zomato allots 35.17 lakh equity shares under ESOP
 ( Corporate News - 01-Aug-24   14:37 )
  Zomato grants 3.18 crore stock options
 ( Corporate News - 11-Jan-24   18:20 )
  Zomato schedules board meeting
 ( Corporate News - 07-May-24   14:13 )
  Zomato spurts after reporting turnaround Q2 numbers
 ( Hot Pursuit - 03-Nov-23   16:40 )
Other Stories
  Board of HCL Technologies recommends Interim Dividend
  14-Jul-25   17:52
  Objectone Information Systems to conduct board meeting
  14-Jul-25   17:50
  JTEKT India AGM scheduled
  14-Jul-25   17:50
  Setco Automotive to discuss results
  14-Jul-25   17:50
  Saurashtra Cement to hold board meeting
  14-Jul-25   17:49
  John Cockerill India to table results
  14-Jul-25   17:49
  ATV Projects India to conduct board meeting
  14-Jul-25   17:49
  Shilchar Technologies schedules AGM
  14-Jul-25   17:49
  Sun Pharma settles litigation related to LEQSELVI™ with Incyte
  14-Jul-25   16:53
  Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
  14-Jul-25   16:48
Back Top